Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check out this report from WallstreetPR.
Why ALBT Merits Close Attention at Deep Discount Levels
AI is already having a major impact on the biotech industry, and its influence is only going to grow in the years to come.
One of the most promising applications of AI in biotech is the development of new drugs and therapies. AI can be used to screen vast libraries of compounds for potential drug candidates and to identify new targets for drug development. AI can also be used to design new drugs that are more likely to be effective and less likely to have side effects.
AI is also being used to improve the efficiency of manufacturing processes in the biotech industry. AI can be used to optimize the production of drugs and therapies and to identify potential problems in the manufacturing process. AI can also be used to automate tasks that are currently performed by humans, which can free up human workers to focus on more complex tasks.
Personalization is a big part of this equation. AI can be used to analyze a patient’s medical data and identify potential risks and vulnerabilities. AI can also be used to recommend personalized treatments for patients.
Overall, AI is being used to develop new drugs and therapies, improve the efficiency of manufacturing processes, and personalize healthcare in meaningful ways. And this has enormous implications for investors looking to position risk capital with a forward-looking mindset.
In other words, this is a breakthrough sub-industry in the making. And investors have yet to fully unearth all the gems emerging in this space.
With that in mind, we take a closer look today at one of the most interesting deep-discount names that fit this premise: Avalon GloboCare Corp. (NASDAQ: ALBT).
Read the full report here....
[/url]https://www.wallstreetpr.com/why-albt-merits-close-attention-at-deep-discount-levels-61133[url]
$ALBT This Biotech has a leading clinical diagnostics tech that could fast-track the company.
Avalon GloboCare Corp. (Nasdaq: ALBT) opened at $3.05 on 3/7/2023, with a weekly average price of $3.25 and its 20-day exponential moving average sitting at $3.71, 50-day moving average at $4.85, and 200-day moving average at $11.49. From here let’s calculate the upside potential if (ALBT) could reach those resistance levels.
First, if shares of (ALBT) were to reach its 20-day exponential moving average of $3.71, there would be a potential upside of 21.97% from the opening price of $3.05 on 3/7/2023.
If shares of (ALBT) were to reach its 50-day moving average of $4.85, there could be a potential upside of 59.02% from the 3/7/2023 opening price of $3.05.
Next, if shares of (ALBT) were to reach its 52-week high of $8.50, there would be a potential gain of 178.69% from the opening price of $3.05.
Then, if shares of (ALBT) were to reach its 200-day moving average of $11.49, there could be a potential upside of 277.70% from the opening price of $3.05.
Finally, if shares of (ALBT) were to reach its 2-year high of $16.50, there could be a potential upside of 440.98% from the opening price of $3.05 on 3/7/2023 and this would also be capping off a 689% move from the $2.09 52-week low put in on 3/3/2023, according to BarChart.com.
As mentioned above, none of these moves are certain. But, the potential needs to be noted.
Moreover, Avalon GloboCare Corp. (Nasdaq: ALBT) has less than 3.3 million shares available in its public float according to MarketWatch.com.
Low float stocks have the potential to present significant swings if active market participants take notice,(49) which could make (ALBT) an attractive watch target for those looking for companies with significant growth potential.
Overall, Avalon GloboCare Corp. (Nasdaq: ALBT) has several possible catalysts including its potential for growth and low public float, making it an attractive option for those looking to watch companies with significant potential.
Maybe that’s why Avalon GloboCare Corp. (Nasdaq: ALBT) insiders are holding onto so many shares according to Finviz.
Strong insider ownership can be an indication of a company’s health and long-term potential. When insiders own a significant percentage of a company’s shares, they have a vested interest in the company’s success, which can align their interests with those of other shareholders.
High insider ownership typically signals that insiders believe in the company’s future prospects and have confidence in its management team.
As of 3/7/2023, Finviz.com is reporting that insiders own over 33% of Avalon GloboCare Corp. (Nasdaq: ALBT), which could be a strong indication of confidence in the company’s future prospects.
This level of insider ownership could be a sign that the management team has a significant stake in the company’s success. When insiders own a large percentage of a company’s shares, it can also indicate that they are committed to the company for the long term, as they have a significant financial stake in its future performance.
The market often views high insider ownership as a positive signal, as it indicates that insiders are financially interested in the company’s success.
This can also provide shareholders with greater transparency into the company’s operations and decision-making processes, as insiders are more likely to share information with shareholders who have a vested interest in the company’s success.
Read the full report here.....
[url][tag]insert-text-here[/tag]https://biotechstockmarketnews.com/this-living-cure-targets-only-cancer-cells/?utm_source=wallstreetpr&utm_medium=affiliate&utm_campaign=albt&_ef_transaction_id=ff8fd205e7234143b056e5130c665ce3[url][tag]insert-text-here[/tag]
Mystery stock hopefully the earnings will show something good.
ALBT.............................https://stockcharts.com/h-sc/ui?s=ALBT&p=W&b=5&g=0&id=p86431144783
Giant news today! Was loaded up in the .40s I knew something was up as the volume started to uptick.
New name and symbol change on November 10th, and trading on the new Nasdaq tier
https://finance.yahoo.com/news/avalon-globocare-signs-definitive-agreement-141000148.html
Check the news today, its giant. Name and ticker change on Thursday, private placement for $1.00 per share. Big things happening, glad I jumped back in the .40s
https://finance.yahoo.com/news/avalon-globocare-signs-definitive-agreement-141000148.html
The buy signal was 11/3 Glad I managed to get in 2 days earlier at .40
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=AVCO
Picked up a good block at .40 as the stock is oversold. Was kind of amazed today with 0 news, and this was up 34% on high volume. Volume precedes price. Something could be brewing. Will see
Looks like basic consolidation is what I’m seeing. Nobody likes it on Fridays but that the way it is! Next week should be better yet
I couldn't agree more. I'm liking this and the way it's trading on a Friday afternoon bodes well for next week. A little bit in the red but not a massive drop.
$AVCO Like this a ton heading into next week..just a little more buying pressure sends this..
Solid start here.Looks good so far.
Looking to close the week out strong..
Add $AVCO as an undiscovered Biotech company…this one has all the makings of making some noise..chart has been green all week long and looking to pop .60
I agree. Really did well yesterday and I'm expecting a good run today as well. Did pretty good considering how light the volume was in the overall market yesterday.
$AVCO Biotech company that should be on everyone’s watchlist and in portfolios..website really opened my eyes..
avalon-globocare.com
$AVCO looks like it wants to gap over the 50 DMA this morning. Might make a run at the 200 DMA today as well https://schrts.co/EpVwsuiC
Starting to move nicely here with some strong volume stepping in.
Still green here and coming up off the low of day. Looks like she'll start moving higher in the coming hour or two.
Volume picks up any the next couple of hours this is going to fly. Looks very strong at open and just need some volume to come kicking in. I think this is about to blast off in my opinion.
$AVCO Some may be shocked at the strong move underway this week..but I’m not.. checkout this companies website and see why I’m very bullish on this company..and take note of the increase in buying volume.very telling..
avalon-globocare.com
$AVCO chart setting up beautifully here, next test will be the 50 DMA https://schrts.co/zNKbGteC
$AVCO Beautiful breakout just underway on the chart as MACD breaking positive..is history is any indication..could see a nice continuation from here..
https://stockcharts.com/c-sc/sc?s=AVCO&p=D&b=5&g=0&i=0&r=1666173165936
Up 7% on strong early volume. Probably within an hour or two will go over the 10-day average on volume and there's a lot of buying taking place here. Looks good.
$AVCO Love this bio Nasdaq company that looks ready to rebound up the chart.. great dd here..
https://chartingdaily.com/The--Next-Golden-ticket
Looks like a double bottom forming up on the monthly. Starting to fill up that right side. Looking for continuation there. Buyers are starting to come in a little heavier in the afternoon session.
Looks like buy volume is stronger than sellers today for AVCO
$AVCO About to pop .50 as this continues to trade green..thinking if we get a solid update this one could really take flight..
Beautiful DD here. Thanks for sharing.
Nice DD package.,thanks for posting it..
$AVCO some great info here in the investor presentation from their website
https://d1io3yog0oux5.cloudfront.net/_26ffe4c7c98f5945e57380bc438b90a2/avalonglobocare/db/298/2133/pdf/Avalon+GloboCare+May+2022+-+New+Final+1.pdf
Don’t forget this chart on AVCO :
I posted a chart on $AVCO because I think it’s a easy winner if it repeats itself. pic.twitter.com/eubHuFndJO
— Crunch (@Crunch1up) October 17, 2022
Strong open here on decent volume. Looks like we might have a good day here.
$AVCO up 6 percent in Premarket as this is starting to get eyes on it over the weekend.. looks like it could pop at the open..
$AVCO hard to ignore this chart, looks like we are approaching another bottom and there have been several spikes from here recently https://schrts.co/IEJFQUDB
Came across $AVCO this weekend and the DD is off the charts..great breakdown here..
https://d1io3yog0oux5.cloudfront.net/_5b20db4643ebbb5cfd5ad5c579f305a0/avalonglobocare/db/298/2133/pdf/Avalon+GloboCare+May+2022+-+New+Final+1.pdf
$AVCO Sneaky play here that could catch lightning with volume..looks like support is in and could spring off it..
https://stockcharts.com/c-sc/sc?s=AVCO&p=D&b=5&g=0&i=0&r=1665951513012
Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX(TM)), and regenerative therapeutics. For more information about Avalon GloboCare, please visit http://www.avalon-globocare.com.
The agreement between Avalon GloboCare and LDHI is subject to negotiation and execution of definitive documentation acceptable to both parties. $AVCO
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
632
|
Created
|
03/07/17
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |